Clinical trials

  • RMD-mILDer: Home based clinical management of Interstitial Lung Disease (ILD) in systemic rheumatic conditions; the Nor-mILDeR randomized strategy trial, including also Romania and Switzerland as participating countries. Included 91 patients in December 2025.
  • The Nor-SSCardioCare pilot study: Home-based clinical management of PAH in systemic sclerosis patients of 12 patients from March-June 2025.
  • I-FILE study – international multicentre home spirometry study in fibrotic interstitial lung diseases. Included 20 patients.
  • 68Ga-DOTATOC PET/CT uptake in systemic sclerosis: a prospective, single-centre pilot study. 8 patients included in 2025
  • CONQUEST: Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.